{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "38845283", "DateRevised": {"Year": "2024", "Month": "06", "Day": "07"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "31"}], "ELocationID": ["S1553-8389(24)00514-1", "10.1016/j.carrev.2024.05.034"], "Journal": {"ISSN": "1878-0938", "JournalIssue": {"PubDate": {"Year": "2024", "Month": "May", "Day": "31"}}, "Title": "Cardiovascular revascularization medicine : including molecular interventions", "ISOAbbreviation": "Cardiovasc Revasc Med"}, "ArticleTitle": "Editorial: Ozone-mediated lumbar renal artery denervation - Another arrow in the quiver?", "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiology, University Heart Center Basel, University Hospital Basel, Switzerland. Electronic address: felix.goetzinger@gmail.com."}], "LastName": "G\u00f6tzinger", "ForeName": "Felix", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiology, University Heart Center Basel, University Hospital Basel, Switzerland."}], "LastName": "Mahfoud", "ForeName": "Felix", "Initials": "F"}], "PublicationTypeList": ["Editorial"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Cardiovasc Revasc Med", "NlmUniqueID": "101238551", "ISSNLinking": "1878-0938"}, "CoiStatement": "Declaration of competing interest F.G. is supported by German Foundation for Heart Research (Deutsche Herzstiftung) and has received speaker honoraria from AstraZeneca. FM is supported by Deutsche Gesellschaft f\u00fcr Kardiologie (DGK), Deutsche Forschungsgemeinschaft (SFB TRR219, Project-ID 322900939), and Deutsche Herzstiftung. Saarland University has received scientific support from Ablative Solutions, Medtronic and ReCor Medical. Until May 2024, FM has received speaker honoraria/consulting fees from Ablative Solutions, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Inari, Medtronic, Merck, ReCor Medical, Servier, and Terumo."}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2024", "Month": "5", "Day": "22"}, {"Year": "2024", "Month": "5", "Day": "28"}, {"Year": "2024", "Month": "6", "Day": "7", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "6", "Day": "7", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "6", "Day": "7", "Hour": "2", "Minute": "6"}], "PublicationStatus": "aheadofprint", "ArticleIdList": ["38845283", "10.1016/j.carrev.2024.05.034", "S1553-8389(24)00514-1"]}}], "PubmedBookArticle": []}